Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | BMS-986012 |
Trade Name | |
Synonyms | |
Drug Descriptions |
BMS-986012 is a monoclonal antibody that binds to the ganglioside fucosyl-GM1, which may lead to anti-tumor immune response (PMID: 30021910). |
DrugClasses | |
CAS Registry Number | 1894272-37-7 |
NCIT ID | C118443 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BMS-986012 | BMS-986012 | 0 | 1 |
BMS-986012 + Carboplatin + Etoposide | BMS-986012 Carboplatin Etoposide | 0 | 1 |
BMS-986012 + Carboplatin + Etoposide + Nivolumab | BMS-986012 Carboplatin Etoposide Nivolumab | 0 | 1 |
BMS-986012 + Cisplatin + Etoposide | BMS-986012 Cisplatin Etoposide | 0 | 1 |
BMS-986012 + Nivolumab | BMS-986012 Nivolumab | 0 | 1 |